144 related articles for article (PubMed ID: 32540209)
1. Serum chitinase-3-like protein 1 is a biomarker of liver fibrosis in patients with chronic hepatitis B in China.
Jin X; Fu B; Wu ZJ; Zheng XQ; Hu JH; Jin LF; Tang LL
Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):384-389. PubMed ID: 32540209
[TBL] [Abstract][Full Text] [Related]
2. The clinical significance of serum chitinase 3-like 1 in hepatitis B-related chronic liver diseases.
Jiang Z; Wang S; Jin J; Ying S; Chen Z; Zhu D; Xiao B; Hu Y; Qian Y; Cai T; Fu L
J Clin Lab Anal; 2020 May; 34(5):e23200. PubMed ID: 31916309
[TBL] [Abstract][Full Text] [Related]
3. Comparison of chitinase-3-like protein 1, aspartate aminotransferase-to-platelet ratio index, and fibrosis-4 index with shear-wave elastography.
Mushtaq S; Ghani E; Azam K; Hussain T
Eur J Gastroenterol Hepatol; 2019 Mar; 31(3):357-362. PubMed ID: 30431458
[TBL] [Abstract][Full Text] [Related]
4. A noninvasive diagnostic model for significant liver fibrosis in patients with chronic hepatitis B based on CHI3L1 and routine clinical indicators.
Huang Q; Wu J; Huang C; Wang X; Xu Z
Ann Palliat Med; 2021 May; 10(5):5509-5519. PubMed ID: 34107703
[TBL] [Abstract][Full Text] [Related]
5. Decrease in Chitinase 3-Like Protein 1 Levels Reflects Improvement in Liver Fibrosis after HCV Eradication.
Kang Q; Chen J; Luo H; Tan N; Gao H; Zhang X; Yu M; Liu D; Xi H; An Y; Han Y; Cheng R; Xu X
Dis Markers; 2020; 2020():8539804. PubMed ID: 33082884
[TBL] [Abstract][Full Text] [Related]
6. [Diagnostic value of serum chitinase-3-like protein 1 in chronic liver disease of significant fibrosis and cirrhosis].
Li H; Yan T; Zhu Z; Bao ZW; Xu TM; Xie J; Zheng SQ; Cui MM; Liu LG
Zhonghua Gan Zang Bing Za Zhi; 2018 May; 26(5):337-341. PubMed ID: 29996200
[No Abstract] [Full Text] [Related]
7. Value of gamma-glutamyltranspeptidase-to-platelet ratio in diagnosis of hepatic fibrosis in patients with chronic hepatitis B.
Hu YC; Liu H; Liu XY; Ma LN; Guan YH; Luo X; Ding XC
World J Gastroenterol; 2017 Nov; 23(41):7425-7432. PubMed ID: 29151696
[TBL] [Abstract][Full Text] [Related]
8. Role of hyaluronic acid and laminin as serum markers for predicting significant fibrosis in patients with chronic hepatitis B.
Li F; Zhu CL; Zhang H; Huang H; Wei Q; Zhu X; Cheng XY
Braz J Infect Dis; 2012; 16(1):9-14. PubMed ID: 22358349
[TBL] [Abstract][Full Text] [Related]
9. Serum angiotensin-converting enzyme level for evaluating significant fibrosis in chronic hepatitis B.
Noguchi R; Kaji K; Namisaki T; Moriya K; Kitade M; Takeda K; Kawaratani H; Okura Y; Aihara Y; Furukawa M; Mitoro A; Yoshiji H
World J Gastroenterol; 2017 Sep; 23(36):6705-6714. PubMed ID: 29085215
[TBL] [Abstract][Full Text] [Related]
10. Serum YKL-40 as a biomarker for liver fibrosis in chronic hepatitis B patients with normal and mildly elevated ALT.
Yan L; Deng Y; Zhou J; Zhao H; Wang G;
Infection; 2018 Jun; 46(3):385-393. PubMed ID: 29600444
[TBL] [Abstract][Full Text] [Related]
11. Serum CHI3L1 as a Biomarker for Non-invasive Diagnosis of Liver Fibrosis.
Bao J; Ouyang Y; Qiao L; He J; Liu F; Wang Y; Miao L; Fu A; Lou Z; Zang Q; Huang W; Huang J; Li Z
Discov Med; 2022; 33(168):41-49. PubMed ID: 36274212
[TBL] [Abstract][Full Text] [Related]
12. The Gamma-Glutamyl-Transpeptidase to Platelet Ratio Does not Show Advantages than APRI and Fib-4 in Diagnosing Significant Fibrosis and Cirrhosis in Patients With Chronic Hepatitis B: A Retrospective Cohort Study in China.
Li Q; Song J; Huang Y; Li X; Zhuo Q; Li W; Chen C; Lu C; Qi X; Chen L
Medicine (Baltimore); 2016 Apr; 95(16):e3372. PubMed ID: 27100421
[TBL] [Abstract][Full Text] [Related]
13. The gamma-glutamyl transpeptidase to platelet ratio for non-invasive assessment of liver fibrosis in patients with chronic hepatitis B and non-alcoholic fatty liver disease.
Li Q; Lu C; Li W; Huang Y; Chen L
Oncotarget; 2017 Apr; 8(17):28641-28649. PubMed ID: 28415736
[TBL] [Abstract][Full Text] [Related]
14. APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B.
Ucar F; Sezer S; Ginis Z; Ozturk G; Albayrak A; Basar O; Ekiz F; Coban S; Yuksel O; Armutcu F; Akbal E
Eur J Gastroenterol Hepatol; 2013 Sep; 25(9):1076-81. PubMed ID: 23510962
[TBL] [Abstract][Full Text] [Related]
15. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
[TBL] [Abstract][Full Text] [Related]
16. Ceruloplasmin, a reliable marker of fibrosis in chronic hepatitis B virus patients with normal or minimally raised alanine aminotransferase.
Zeng DW; Dong J; Jiang JJ; Zhu YY; Liu YR
World J Gastroenterol; 2016 Nov; 22(43):9586-9594. PubMed ID: 27920479
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: the role in primary care setting.
Lesmana CR; Salim S; Hasan I; Sulaiman AS; Gani RA; Pakasi LS; Lesmana LA; Krisnuhoni E; Budihusodo U
J Clin Pathol; 2011 Oct; 64(10):916-20. PubMed ID: 21670074
[TBL] [Abstract][Full Text] [Related]
18. Gamma-glutamyl transpeptidase to platelet ratio index is a good noninvasive biomarker for predicting liver fibrosis in Chinese chronic hepatitis B patients.
Wang RQ; Zhang QS; Zhao SX; Niu XM; Du JH; Du HJ; Nan YM
J Int Med Res; 2016 Dec; 44(6):1302-1313. PubMed ID: 28322102
[TBL] [Abstract][Full Text] [Related]
19. [Diagnostic value of novel hepatic fibrosis markers in assessing cirrhosis in patients with chronic hepatitis C].
Kang Q; Liu JX; Tan N; Chen HY; Pan JL; Han YF; Xu XY
Zhonghua Gan Zang Bing Za Zhi; 2023 Jan; 31(1):56-64. PubMed ID: 36948850
[No Abstract] [Full Text] [Related]
20. Evaluation of serum procollagen C-proteinase enhancer 1 level as a fibrosis marker in patients with chronic hepatitis B.
Gokce O; Ozenirler S; Atak Yucel A; Oruklu N; Yilmaz Esendagli G; Karahan S
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):918-924. PubMed ID: 29683980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
